Dialysis Clinical Trials in Chengdu, Sichuan
3 recruitingChengdu, Sichuan, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
HyperphosphatemiaDialysisChronic Kidney Disease, Receiving Dialysis+1 more
Alebund Pharmaceuticals264 enrolled42 locationsNCT06933472
Recruiting
Not Applicable
Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients
Peritoneal Dialysis ComplicationSodium-glucose Co-transporter-2 InhibitorsRenal Function Aggravated
Sichuan Academy of Medical Sciences70 enrolled1 locationNCT06398977
Recruiting
Not Applicable
Exercise Improves Gastrointestinal Function in Peritoneal Dialysis Patients
ExerciseQuality of LifeChronic Kidney Diseases+2 more
Sichuan Academy of Medical Sciences132 enrolled1 locationNCT06368713